Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00986661
What this trial is testing

Assess PV-10 Chemoablation of Cancer of the Liver

Who this might be right for
Cancer Metastatic to the LiverHepatocellular CarcinomaMetastatic Melanoma+7 more
Provectus Biopharmaceuticals, Inc. 78
Not applicableUnknownNCT02979470
What this trial is testing

Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers

Who this might be right for
Colon Cancer Stage IIbRectum Cancer, AdenocarcinomaColon Cancer Stage IIIa+2 more
AC Camargo Cancer Center 100
Early research (Phase 1)Study completedNCT00635596
What this trial is testing

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Who this might be right for
Solid Tumors
Amgen Research (Munich) GmbH 65
Large-scale testing (Phase 3)Study completedNCT00025337
What this trial is testing

Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 880
Not applicableStudy completedNCT02022995
What this trial is testing

Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients

Who this might be right for
Colon Cancer Adenocarcinoma
National Taiwan University Hospital 180
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Testing effectiveness (Phase 2)Study completedNCT03085914
What this trial is testing

Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)

Who this might be right for
Solid Tumor
Incyte Corporation 70
Testing effectiveness (Phase 2)Study completedNCT03366155
What this trial is testing

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerLiver MetastasesColorectal Adenocarcinoma+2 more
National Cancer Institute (NCI) 24
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)WithdrawnNCT02287727
What this trial is testing

Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment

Who this might be right for
Rectal AdenocarcinomaStage IIA Rectal CancerStage IIB Rectal Cancer+3 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Early research (Phase 1)UnknownNCT00016042
What this trial is testing

Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer

Who this might be right for
Colorectal CancerKidney Cancer
St. Luke's Medical Center
Early research (Phase 1)Looking for participantsNCT04511039
What this trial is testing

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Gastroesophageal Junction AdenocarcinomaClinical Stage IV Gastroesophageal Junction Adenocarcinoma+26 more
Roswell Park Cancer Institute 45
Testing effectiveness (Phase 2)Study completedNCT00080951
What this trial is testing

Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 14
Early research (Phase 1)Ended earlyNCT04108481
What this trial is testing

Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticColon CancerMetastatic Colorectal Cancer+7 more
University of Iowa 5
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Not applicableActive Not RecruitingNCT02293954
What this trial is testing

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Who this might be right for
Breast CancerColon CancerExtrahepatic Bile Duct Cancer+9 more
City of Hope Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07659795
What this trial is testing

VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

Who this might be right for
Colorectal Cancer
Verastem, Inc. 150
Testing effectiveness (Phase 2)WithdrawnNCT06690281
What this trial is testing

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more
National Cancer Institute (NCI)
Next Page